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INTRODUCTION
There is now abundant evidence that
the immune system and the brain have
close functional interactions in both direc-
tions. This review focuses on the influence
of the microbiota (the bacteria resident
in the gut) on brain function in major
depressive disorder (MDD) and related
syndromes.
The gut and the central nervous system
communicate partly through the auto-
nomic nervous system (ANS), consisting
of the sympathetic (i.e., the splanchnic
nerves) and the parasympathetic (i.e., the
vagus nerve and the sacral parasympa-
thetic pelvic nerves) nervous system. The
brain integrates inputs from the digestive
tract by a central autonomic network that
includes the hypothalamus, limbic system
and cerebral cortex with output to the ANS
and hypothalamic-pituitary-adrenal gland
(HPA) stress axis (Bonaz, 2013). There are
also extensive chemical signaling systems
via the blood.
GUT-BRAIN INTERACTIONS IN MDD
Altered immune responses and increased
inflammation have been demonstrated in
MDD (Herbert and Cohen, 1993; Licinio
and Wong, 1999; Miller et al., 2009a,b;
Dowlati et al., 2010; Maes, 2011; Raedler,
2011; Frodl and Amico, 2014). These
stressful reactions are mediated in part
by pro-inflammatory cytokines (and other
signaling molecules) that originate in
the intestinal mucosa and interact with
the hypothalamic–pituitary–adrenal gland
(HPA) stress axis and neurotransmitter
metabolism at various levels. Risk factors
include psychosocial stressors, diets with
high levels of refined carbohydrates and
saturated fatty acids, low physical activity,
smoking, obesity and vitamin D deficiency
(Berk et al., 2013).
Stress-induced pro-inflammatory
cytokines can elicit profound changes
in brain function and behavior, which
include the initiation of depressive symp-
toms, such as sad mood, anhedonia,
fatigue, psychomotor retardation, and
social-behavioral withdrawal (Slavich and
Irwin, 2014). High levels of interleukin
(IL)-6, C-reactive protein, tumor necro-
sis factor (TNF)-α, and neopterin are
found in patients suffering from MDD
(Müller, 2014). Indeed, cytokine recep-
tors are present in neurons and glial
cell populations in discrete brain regions
(Arisi, 2014), including the hypothalamus,
nucleus accumbens, hippocampus, thala-
mus, cortex, and cerebellum. Moreover,
cytokines have direct and indirect effects
on neurotransmitter storage and release
by microglia cells and astrocytes. This
includes the tryptophan kynurenine
metabolic pathway. This key enzyme
that degrades serotonin—indoleamine
2, 3-dioxygenase—is driven by pro- and
anti-inflammatory cytokines. Neuronal
levels of serotonin play a key role in MDD.
Moreover, neuroactive kynurenines, such
as kynurenic acid and quinolinic acid,
act on the glutamatergic neurotransmis-
sion as N-methyl-D-aspartate antagonists
and agonists, respectively. Severe infec-
tions and autoimmune disorders are
lifetime risk factors for MDD (Müller,
2014). Stress may even contribute to a
lasting pro-inflammatory state. Further
supportive evidence is provided by the
therapeutic benefit in MDD of anti-
inflammatory medications, such as
cyclo-oxygenase-2 inhibitors, TNF-α
antagonists and others, and the anti-
inflammatory and immunomodulatory
intrinsic effects of antidepressants (Müller,
2014).
Brain function encoding emotion
also depends on interoceptive signals
such as visceral pain. In irritable bowel
syndrome (IBS), which is characterized
by chronic recurrent abdominal pain,
disorder of brain-gut function may be
associated with corticotropin-releasing
hormone (CRH) and/or serotonin, since
administration of CRH exacerbates the
visceral sensorimotor response, whereas
inhibition of CRH or serotonin with
their respective antagonists or antide-
pressants is protective (Fukudo, 2013).
Moreover, studies of congential insen-
sitivity to pain with anhidrosis (CIPA)
show that the Nerve Growth Factor–TrkA
system is essential for the establishment
of a neural network for interoception
and homeostasis that may underlie “gut
feelings” (Indo, 2009). The complex
interplay of neuro-endocrine-immune
top-down and bottom-up pathways
in IBS, closely related to neuropsychi-
atric disorders, is well reviewed by Stasi
et al. (2012) and in functional dys-
pepsia by Van Oudenhove and Aziz
(2013).
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THE “LEAKY GUT” HYPOTHESIS
In recent papers Berk et al. (2013), Lucas
and Maes (2013), and McCusker and
Kelley (2013) have presented the “leaky
gut” hypothesis, which suggests that a
key mechanism involved in MDD may be
increased permeability of the gut epithe-
lium, leading to the abnormal intesti-
nal absorption of luminal bacteria that,
under normal circumstances, would be
restricted to the gut lumen by the epithe-
lial barrier. Bacteria carry on their surfaces
a variety of pathogen-associated molecu-
lar patterns (PAMPs) that are recognized
by specific receptors (PRRs) located both
on the surface membrane (e.g., toll-like
receptors (TLRs)) and in the cytoplasm
(e.g., nucleotide-binding oligomerization
domain (Nod)-like receptors) of cells
belonging to the innate immune sys-
tem, primarily macrophages and dendritic
cells (DCs) (Leulier and Lemaitre, 2008;
McCusker and Kelley, 2013). If the epithe-
lial barrier is circumvented, bacteria [or
molecules from them, such as lipopolysac-
charides (LPS)] penetrating the intesti-
nal mucosa may bind to their cognate
TLRs (in particular TLR-4), driving NF-
κβ activation, stimulating the expression
of pro-inflammatory cytokines, including
IL-1 and TNF-α, and facilitating the syn-
thesis of arachidonic-acid derivates (Feng
et al., 1995; Verstrepen et al., 2008), all of
which are implicated in MDD.
Evidence supporting this hypothesis
includes the following findings. First,
chronic mild stress increases the level of
bacterial LPS in the circulation of rats,
driving activation of the TLR-4 pathway
on blood monocytes (Gárate et al., 2011,
2013), and production of immunoglob-
ulins against LPS is increased in MDD
(Maes et al., 2008; Maes and Kubera,
2012; Maes et al., 2013). Second, exposure
to stress activates TLR-4 signaling in the
frontal cortex of mice (Gárate et al., 2011),
resulting in oxidative and nitrosative neu-
ronal damage. Lastly, Kéri et al. (2014)
reported that expression of TLR-4 RNA
and protein, NF-κB and 16S RNA (a sub-
unit of intestinal microbiota) were raised
in the plasma of patients with MDD com-
pared to healthy controls, and their mag-
nitude correlated with the severity of the
clinical symptoms.
TLRs are also expressed on neu-
rons and are thought to regulate
neurodevelopment, dendritic cell growth
and behavior in mice (Liu et al., 2013).
Additionally, some bacteria can also
directly activate nociceptive neurons by
evoking calcium flux and action potentials
without involving TLRs (Chiu et al., 2013),
a mechanism that involves bacterial N-
formylated peptides and the pore-forming
toxin alpha-hemolysin. These bacterial
toxins and cytokines (or signals from
them) are transported to the brain by ner-
vous pathways (e.g., vagal signaling via the
n. tractus solitarius to the hypothalamus
and amygdala) and humeral transport via
the lymph and blood. Sako et al. (2005)
studied c-FOS expression in the brain
in response to peripheral administra-
tion of bacterial CpG, reporting increased
numbers of c-FOS-positive cells in the par-
aventricular nucleus of the hypothalamus,
the nucleus of the tractus solitarius (NTS)
and the area postrema, independently of
the afferent vagus nerve input. A possible
carrier for bacterial toxins, including CpG-
DNA, from the gut lumen into the brain
may be exosomes (see further below).
The pertinent questions now relate to
the nature of the mechanism (i) by which
microbiotic toxins and their effects are
transmitted from the gut to the brain and
(ii) what specific mechanisms in the brain
are affected. Kéri et al. (2014) stipulate that
this involves bacterial translocation or “the
presence of various damage-associated
molecular patterns.”
EXOSOMES
We can now ask what is the mechanism by
which bacterial toxins cross the intestinal
endothelium. One established mechanism
is provided by sub-epithelial intestinal
DCs that insert dendrites between epithe-
lial cells to harvest luminal bacteria or
soluble products from the gut lumen
(McDole et al., 2012). We suggested pre-
viously that this cargo may be transported
within exosomes (small lipoprotein vesi-
cles that contain protein, nucleic acids,
sugars and lipids), and transferred from
the DCs to T cells in the draining lymph
nodes, where they can modulate inflam-
matory responses (Smythies and Smythies,
2014). We now add a further detail to
this hypothesis, whereby PSA-labeled exo-
somes released by bacteria in the gut
lumen may also be taken up by intesti-
nal DCs and carried to the lymph nodes,
to activate T-cell immune responses (Shen
et al., 2012). Thus, T cells can receive epi-
genetic material from gut bacteria, either
by direct endocytosis, or via afferent exo-
somes. Moreover, exosomes entering the
general circulation, via the lymph and
blood, can be transmitted to the brain with
subsequent effects on the brain’s inflam-
matory system as we described earlier.
Lastly, exosomes themselves influence the
properties of the blood-brain barrier to
facilitate their passage into the brain. This
involves changes in the membrane electric
resistance and capacitance (Ridder et al.,
2014).
But how would psychological stress
activate this pathway? Since exosome traf-
fic between cells is usually bidirectional,
one mechanism could be that stress, via
the CRH—HPA pathway, could alter the
epigenetic content of exosomes exported
from DCs into the lumen and taken
up by gut bacteria, thereby altering bac-
terial profiles, and modulating the epi-
genetic loads of exosomes (particularly
miRNAs) subsequently exported from
these bacteria and taken up by intesti-
nal DCs. Indeed, olfactory bulbectomy
mice demonstrate chronic depression-
and anxiety-like behaviors associated with
elevated central CRH expression and
increased c-Fos activity, serotonin levels,
and motility in the colon (Park et al.,
2013). These changes are accompanied
by an altered intestinal microbial pro-
file. Central CRH administration produces
similar changes in behavior and motility
and altered the microbiota profile in the
colon. Remarkably, the alteration of the
microbial profile in the colon produced
by acute social stress is required for the
latter to increase circulating cytokine lev-
els (Bailey et al., 2011). The monumental
complexities of the epigenetic regulation
(particularly by DNA methylation) of
stress related functions in the brain have
been well reviewed by Klengel et al. (2014).
For a general review of the role of epi-
genetic mechanisms in information pro-
cessing in the brain see Edelstein et al.
(2014).
Bretz et al. (2013) report that exosomes,
isolated from various body fluids that were
internalized by THP-1 cells, induced the
production of IL-1β, TNF-α, and IL-6. The
signaling pathways involved a fast trigger-
ing of NF-κB and a delayed activation of
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the transcription factor STAT3. The ini-
tial production of IL-6 was necessary for
the STAT3 activation. Exosomal signal-
ing was TLR-dependent as the knockdown
of TLR2 and TLR4 blocked NF-κB and
STAT3 activation.
PSYCHOBIOTICS
Therapeutic modifications of the gut
microbiota may be achieved by feeding
certain bacteria such as some Lactobacilli.
Alterations in the central expression of
GABA are implicated in the pathogene-
sis of anxiety and depression (Bravo et al.,
2011). These workers report that chronic
administration of Lactobacillus rhamno-
sus induces region specific changes in
the expression of GABA (B1b) mRNA
in the brain with increases in the cin-
gulate and prelimbic cortices and reduc-
tions in the hippocampus, amygdala and
locus coeruleus. It also reduced GABA
(Aa2) mRNA expression in the prefrontal
cortex and amygdala but increased this
measure in the hippocampus. Lactobacillus
rhamnosus feeding also reduced stress-
induced corticosterone levels and anxiety
and depression-related behaviors. These
findings were abolished following vago-
tomy. Thus, the vagus must carry this sig-
nal from the gut to the brain. The use
of psychobiotics (such as Bifidobacterium
infantis) in relieving anxiety and depres-
sion associated with IBS is reviewed by
Dinan and Cryan (2013). Ait-Belgnaoui
et al. (2014) report that pretreatment
with a combination of Lactobacillus hel-
veticus and Bifidobacterium longum atten-
uated stress-induced activation of the HPA
axis and the autonomic nervous system,
reducing cFos expression in several brain
areas, as well as reducing stress-induced
hippocampal neurogenesis and expression
changes in genes in the hypothalamus con-
cerned in synaptic plasticity. The thera-
peutic applications of differential bacterial
colonizations is reviewed by Buffie and
Pamer (2013).
The powerful effect on the microbiota
during Clostridium difficile (CD) infec-
tions may affect the mood in addition
to the distress caused by the symptoms.
The use of antidepressant medications
increases the risk of developing CD infec-
tion (Rogers et al., 2013). Oral administra-
tion of vancomycin significantly impacts
host physiology by decreasing intestinal
microbiota diversity, bile acid dehydrox-
ylation and peripheral insulin sensitivity
(Vrieze et al., 2014).
CONCLUSION
This paper reviews the present status
of the “leaky gut” hypothesis relating
to MDD and adds some details of the
molecular and cellular mechanisms that
may be involved. This hypothesis suggests
that a key mechanism involved in MDD
may be increased gut permeability, abnor-
mal intestinal absorption of gram-negative
bacteria, and subsequent activation of the
TLR/NF-κB pathway in innate immune
cells of the gut mucosa, or on neu-
rons themselves. This activation induces
the release of pro-inflammatory cytokines
with a deleterious effect on a number of
brain mechanisms involved in stress. We
suggest that exosomes may play a promi-
nent part in this process.
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